“Heart-failure-omics”---.., causal genes, potential drug targets, and biomarkers of clinical value..
1., Heart Failure,. Saunders, MD*; Vijay Nambi, MD*; James A. de Lemos, MD; Lloyd E. Chambless, PhD;
15, 2009; accepted June 25, 2010. Background—(AF).. Methods and Results— Thirty-four haplotype
Contents:Volume 115, Issue 14; April 10, 20071. C-Terminal Provasopressin (Copeptin).(LAMP) Study So
1., MD; Hiroyuki Hao, MD, PhD; Tetsuo Minamino, MD, PhD; Kouki Watanabe, MD, PhD; Kensaku Nishihira,
ST-T改变,偶发房性期前收缩及偶发室性期前收缩,再次入院。彩超提示:EF57%左房左室内径增大,左室下间隔、下侧壁、下壁基底段及前、下室间隔中段缺血改变。心肌酶阴性。心电图见“心电图2”。复查冠脉